We are live on ! Find out more
AG

Artal Group Portfolio holdings

AUM $931M
1-Year Est. Return 41.63%
This Fund
S&P 500
This Quarter Est. Return
+37.81%
1 Year Est. Return
+41.63%
3 Year Est. Return
+181.18%
5 Year Est. Return
+113.34%
10 Year Est. Return
+1,823.73%
AUM
$4.66B
AUM Growth
+$539M
Cap. Flow
+$598M
Cap. Flow %
12.83%
Top 10 Hldgs %
41.2%
Holding
160
New
26
Increased
26
Reduced
23
Closed
30

Top Buys

Rank Stock Value
1
SEER icon
Seer Inc
SEER
+$372M
2
KRON
Kronos Bio
KRON
+$41.3M
3
SQZ
SQZ Biotechnologies Company
SQZ
+$41M
4
Z icon
Zillow
Z
+$38.7M
5
CCXI
ChemoCentryx, Inc.
CCXI
+$37.2M

Top Sells

Rank Stock Value
1
BNTX icon
BioNTech
BNTX
+$71.8M
2
BABA icon
Alibaba
BABA
+$62.5M
3
MRNA icon
Moderna
MRNA
+$25.3M
4
STNE icon
StoneCo
STNE
+$21.2M
5
SRRK icon
Scholar Rock
SRRK
+$14.3M

Sector Composition

Rank Sector Weight
1 Healthcare 78.81%
2 Consumer Discretionary 9.12%
3 Miscellaneous 6.2%
4 Technology 2.01%
5 Communication Services 1.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IRWD icon
126
Ironwood Pharmaceuticals
IRWD
$676M
$1.26M 0.03%
110,532
– –
RIGL icon
127
Rigel Pharmaceuticals
RIGL
$836M
$1.12M 0.02%
32,110
– –
SURF
128
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$924K 0.02%
+100,000
New +$869K
CEREW
129
DELISTED
Cerevel Therapeutics Holdings, Inc. Warrant
CEREW
$450K 0.01%
+79,600
New +$321K
CDTX
130
DELISTED
Cidara Therapeutics
CDTX
$449K 0.01%
11,234
– –
AAPL icon
131
CALL
Apple
AAPL
$4.81T
– –
-200,000
Closed -$23.2M
ADPT icon
132
Adaptive Biotechnologies
ADPT
$4.3B
– –
-100,000
Closed -$4.86M
AUTL
133
Autolus Therapeutics
AUTL
$506M
– –
-285,000
Closed -$3.32M
AXDX
134
DELISTED
Accelerate Diagnostics
AXDX
– –
-42,750
Closed -$4.56M
BAC icon
135
CALL
Bank of America
BAC
$417B
– –
-2,000,000
Closed -$48.2M
C icon
136
CALL
Citigroup
C
$229B
– –
-500,000
Closed -$21.6M
CTMX icon
137
CytomX Therapeutics
CTMX
$595M
– –
-178,600
Closed -$1.19M
ESPR
138
DELISTED
Esperion Therapeutics
ESPR
– –
-250,000
Closed -$9.29M
GM icon
139
CALL
General Motors
GM
$74.9B
– –
-500,000
Closed -$14.8M
GS icon
140
CALL
Goldman Sachs
GS
$284B
– –
-875,000
Closed -$176M
IDYA icon
141
IDEAYA Biosciences
IDYA
$3.62B
– –
-8
Closed –
JPM icon
142
CALL
JPMorgan Chase
JPM
$940B
– –
-1,000,000
Closed -$96.3M
MRUS
143
DELISTED
Merus
MRUS
– –
-250,000
Closed -$3M
MS icon
144
CALL
Morgan Stanley
MS
$323B
– –
-500,000
Closed -$24.2M
NERV icon
145
Minerva Neurosciences
NERV
$183M
– –
-95,000
Closed -$2.42M
OXY icon
146
Occidental Petroleum
OXY
$63.2B
– –
-375,000
Closed -$3.75M
PASG icon
147
Passage Bio
PASG
$15.4M
– –
-782
Closed -$205K
PMVP icon
148
PMV Pharmaceuticals
PMVP
$74.3M
– –
-200,000
Closed -$7.1M
PRTA icon
149
Prothena Corp
PRTA
$429M
– –
-351,500
Closed -$3.51M
QQQ icon
150
PUT
Invesco QQQ Trust
QQQ
$474B
– –
-2,058,000
Closed -$572M
3 4 5
6
7

Similar funds

BCM
Bronte Capital Management Bondi Junction, Australia $931M AUM 47.97% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $931M AUM 4.95% 1-Year Est. Return
SAM
Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return
NS
Night Squared New York $930M AUM 56.46% 1-Year Est. Return
PA
Planning Alternatives Birmingham, Michigan $933M AUM 28.32% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $933M AUM 56.2% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $929M AUM 53.07% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

Artal Group's Q4 2020 Portfolio in Review

As of Q4 2020, Artal Group held 160 positions worth $4.66B, up 13% from $4.12B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Artal Group deployed $598M of net new capital in Q4 2020, opening 26 new positions and adding to 26 existing holdings. Its largest new stake was Seer Inc: 5,840,911 shares worth $328M.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, up from 58% a quarter earlier, followed by Consumer Discretionary and Miscellaneous.

On the sell side, the largest reduction was BioNTech, an estimated $71.8M trimmed.

  • Artal Group's largest Q4 2020 buy was Seer Inc: 5,840,911 shares worth $328M.
  • Artal Group added most to Zillow in Q4 2020, an estimated $38.7M increase.
  • Artal Group's biggest Q4 2020 reduction was BioNTech, cutting an estimated $71.8M.
  • Artal Group fully exited StoneCo in Q4 2020, selling an estimated $21.2M.
  • Artal Group's ten largest holdings make up 41% of its $4.66B portfolio in Q4 2020.
  • Artal Group opened 26 new positions and closed 30 in Q4 2020.
  • Artal Group's portfolio value rose 13% quarter-over-quarter to $4.66B.

Based on Artal Group's 13F filing for Q4 2020, filed 11 Feb 2021.